Merck KGaAFRA:MRKC +3.76%81 FCF Margin % is 5.30% as of Mar. 2026, which is 52% below its 10-year median of 10.98. GuruFocus rates FRA:MRKC with a GF Score™ of 81/100 and a GF Value™ of €27.71 (Fairly Valued). The stock has 9 warning signs investors should review. Among 958 Drug Manufacturers companies, Merck KGaA ranks better than 71.82% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Merck KGaA's Free Cash Flow for the
three
months ended in Mar. 2026 was €272 Mil. Merck KGaA's Revenue for the
three
months ended in Mar. 2026 was €5,134 Mil. Therefore, Merck KGaA's FCF Margin % for the quarter that ended in Mar. 2026 was 5.30%.
The historical rank and industry rank for Merck KGaA's FCF Margin % or its related term are showing as below:
FRA:MRKC'
s FCF Margin % Range Over the Past 10 Years
Min: 8.11 Med: 10.98 Max: 16.23
Current: 10.57
During the past 13 years, the highest FCF Margin % of Merck KGaA was 16.23%. The lowest was 8.11%. And the median was 10.98%.
FRA:MRKC's FCF Margin % is ranked better than 71.82% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.445
vs FRA:MRKC: 10.57
Merck KGaA FCF Margin % Related Terms
Merck KGaA FCF Margin % Historical Data
* Premium members only.
The historical data trend for Merck KGaA's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MRKC vs ZTS, UTHR, VTRS: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merck KGaA FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Merck KGaA's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merck KGaA (FRA:MRKC) has a FCF Margin % of 5.30% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Merck KGaA and its competitors. This is 52% below median its historical median of 10.98. Over the past decade, Merck KGaA's FCF Margin % has ranged from 8.11 to 16.23. According to the industry distribution chart, Merck KGaA ranks #270 out of 958 companies in the Drug Manufacturers industry, placing it in the top 28.2%.
Is Merck KGaA's FCF Margin % too high?
Merck KGaA's current FCF Margin % of 5.30% is 52% below median its 10-year median of 10.98. Over the past 10 years, this metric has ranged from a low of 8.11 to a high of 16.23. The Drug Manufacturers industry median FCF Margin % is 2.45. Merck KGaA's value of 5.30% is 116.8% above this industry median. Based on the distribution chart, Merck KGaA ranks #270 out of 958 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Merck KGaA has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Merck KGaA's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Merck KGaA ranks #270 out of 958 companies for FCF Margin %. This puts Merck KGaA in the upper half of its industry. The industry median FCF Margin % is 2.45. Merck KGaA's value of 5.30% is 116.8% above this benchmark. Historically, Merck KGaA's own FCF Margin % has ranged from 8.11 to 16.23 over the past decade. While the company's 10-year median is 10.98 vs. the industry median of 2.45, Merck KGaA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Merck KGaA's current FCF Margin % of 5.30% is 116.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Merck KGaA and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Merck KGaA's current FCF Margin % is 5.30%, which is 52% below median its own 10-year median of 10.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck KGaA stock overvalued right now?
Based on GuruFocus' analysis, Merck KGaA (FRA:MRKC) is currently considered Fairly Valued. The stock's GF Value™ is €27.71, compared to a current price of €27.60 — trading 0.4% below its estimated fair value. The current FCF Margin % is 5.30%, which is 52% below median its 10-year median of 10.98 and 116.8% above the Drug Manufacturers industry median of 2.45. Merck KGaA's overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Merck KGaA (FRA:MRKC), the current FCF Margin % is 5.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Merck KGaA (FRA:MRKC) Overvalued in 2026?
Based on GuruFocus' analysis, Merck KGaA stock appears to be undervalued.
The current stock price of €27.60 is trading 0.4% below its estimated GF Value™ of €27.71.
GuruFocus considers Merck KGaA to be Fairly Valued.
Key valuation signals for FRA:MRKC:
FCF Margin %: 5.30% (52% below median its 10-year median of 10.98)
GF Value™: €27.71 vs. price of €27.60 (0.4% below fair value)
Industry Position: 116.8% above the Drug Manufacturers median (#270 of 958)
No single metric tells the full story. See the FRA:MRKC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
81GF Score
Get the complete analysis for FRA:MRKC
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MRKC has been successfully added to your 
